Label Comprehension “Yes/No” Questions Should Be Avoided, FDAer Says
This article was originally published in The Tan Sheet
Executive Summary
Drug sponsors should avoid using "yes/no" questions in label comprehension tests for Rx-to-OTC switch candidates, FDA's Karen Lechter, PhD, advised at the Consumer Healthcare Products Association's Research & Scientific Development Conference in Washington, D.C. Nov. 8